U.S. Markets closed

Koninklijke Philips N.V. (PHIA.AS)

Amsterdam - Amsterdam Precio retrasado. Divisa en EUR.
Añadir a la lista de seguimiento
18.77-0.06 (-0.31%)
Al cierre: 05:39PM CET

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
31 20 597 7777

IndustriaMedical Devices
Empleados a tiempo completo70,741

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. Roy JakobsPresident, CEO & Chairman of the Board of Management1.28MN/D1974
Dr. Paulus A. Stoffels M.D., Ph.D.Independent Vice Chairman of Supervisory Board & Secretary177.27kN/D1962
Mr. Abhijit BhattacharyaExecutive VP, CFO & Member of the Board of Management1.13M485.44k1961
Mr. Marnix J. van GinnekenExecutive VP, Chief ESG, Legal Officer & Member of the Board of Management831.35k244.75k1973
Mr. Willem AppeloExecutive VP & COON/DN/D1965
Mr. Leandro MazzoniHead of Investor RelationsN/DN/DN/D
Ms. Daniela SeabrookExecutive VP & Chief Human Resources OfficerN/DN/D1973
Mr. Sean CarneyChief Design OfficerN/DN/DN/D
Mr. Andy HoExecutive VP & Chief Market Leader of Philips Greater ChinaN/DN/D1961
Jan KimpenChief Medical OfficerN/DN/D1958
Los importes son a partir de 31 de diciembre de 2022 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.


Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Gestión corporativa

La calificación ISS Governance QuickScore de Koninklijke Philips N.V. a partir del 28 de noviembre de 2023 es 3. Las puntuaciones principales son Auditoría: 1; Junta: 1; Derechos del accionista: 5; Compensación: 6.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.